CD4 and ovarian cancer: In ovarian cancer, hypoxia-induced angiogenesis, human, and mouse CD4+CD25+ Tregs secrete higher amounts of VEGFA (as compared to CD4+CD25− T cells) and promote EC proliferation in vitro and in vivo (179).